Related Experiment Videos
Malignant melanoma: biotherapeutic strategies for management with the interferons
V Ruocco1, R A Satriano, G Castello
1Department of Dermatology, First School of Medicine, University of Naples Federico II, Italy.
Clinics in Dermatology
|October 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Laparoscopic pancreaticoduodenectomy for tumors of the head of pancreas; 10 cases for a single center experience.
European review for medical and pharmacological sciences·2017
Crohn's disease and skin.
United European gastroenterology journal·2016
GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues.
European journal of histochemistry : EJH·2015
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea.
United European gastroenterology journal·2015
Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry.
European journal of histochemistry : EJH·2015
S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms.
British journal of pharmacology·2014
The Menopause Supplement Gold Rush: Ethical Obligations in Dermatology.
Clinics in dermatology·2026
Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology.
Clinics in dermatology·2026
High-Resolution Ultrasound in Alopecias: Principles, Sonoanatomy, and Imaging Patterns.
Clinics in dermatology·2026
GLP-1 Receptor Agonists in Dermatology: Ethical Considerations.
Clinics in dermatology·2026
Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.
Clinics in dermatology·2026
Prediction Markets in Dermatology: Ethical Considerations for Physicians.
Clinics in dermatology·2026
Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.
Journal of medicinal chemistry·2026
Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.
Journal of medicinal chemistry·2026
Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.
Frontiers in aging·2026